Koyfin Home > Directory > Health Care > Aeglea Biothera > Capital Expenditures

Aeglea Biothera Capital Expenditures Chart (AGLE)

Aeglea Biothera annual/quarterly Capital Expenditures from 2014 to 2020.
  • Aeglea Biothera Capital Expenditures for the quarter ending June 06, 2020 was $-1m a 89.21% decrease of -1m year over year
  • Aeglea Biothera Capital Expenditures for the last 12 months ending June 06, 2020 was $-4m a 87.08% decrease of -4m year over year
  • Aeglea Biothera Annual Capital Expenditures for 2019 was $-1m a 71.72% decrease of -1m from 2018
  • Aeglea Biothera Annual Capital Expenditures for 2018 was $0m a -46.68% increase of 0m from 2017
  • Aeglea Biothera Annual Capital Expenditures for 2017 was $-1m a 65.75% decrease of 0m from 2016
Other Cash Flow Metrics:
  • Aeglea Biothera Cash Flow from Operations for the quarter ending December 12, 2018 was $-7m a -3.43% increase of 0m year over year
  • Aeglea Biothera Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-6m a 25.45% decrease of -2m year over year
  • Aeglea Biothera Total Revenue for the quarter ending June 06, 2018 was $2m a 46.97% increase of 1m year over year
View Chart On Koyfin

Quarterly AGLE Capital Expenditures Data

06/2020$-1m
03/2020$-1m
12/2019$-1m
09/2019$0m
06/2019$0m
03/2019$0m
12/2018$0m
09/2018$0m
06/2018$0m
03/2018$0m

Annual AGLE Capital Expenditures Data

2019$-1m
2018$0m
2017$-1m
2016$0m
2015$0m
2014$0m